世界の関節疾患治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Joint Disease Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12411 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、関節疾患治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。関節疾患治療の種類別市場規模（薬物療法、リハビリテーション、外科手術）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・関節疾患治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、Pfizer、Bristol-Myers Squibb、Roche、GlaxoSmithKline、AstraZeneca、Astellas Pharma、Johnson&Johnson、Amgen、Novartis、Sanofi、Daiiachi Sankyo ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：薬物療法、リハビリテーション、外科手術 ・用途別分析2016年-2026年：病院、クリニック、その他 ・関節疾患治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・関節疾患治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・関節疾患治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・関節疾患治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・関節疾患治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Joint Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Joint Disease Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Joint Disease Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Joint Disease Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Drug Therapy
Rehabilitation
Surgical Operation

Market segment by Application, can be divided into
Hospital
Clinic
Others

Market segment by players, this report covers
AbbVie
Pfizer
Bristol-Myers Squibb
Roche
GlaxoSmithKline
AstraZeneca
Astellas Pharma
Johnson&Johnson
Amgen
Novartis
Sanofi
Daiiachi Sankyo

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Joint Disease Therapeutics
1.2 Classification of Joint Disease Therapeutics by Type
1.2.1 Overview: Global Joint Disease Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Joint Disease Therapeutics Revenue Market Share by Type in 2020
1.2.3 Drug Therapy
1.2.4 Rehabilitation
1.2.5 Surgical Operation
1.3 Global Joint Disease Therapeutics Market by Application
1.3.1 Overview: Global Joint Disease Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Joint Disease Therapeutics Market Size & Forecast
1.5 Global Joint Disease Therapeutics Market Size and Forecast by Region
1.5.1 Global Joint Disease Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Joint Disease Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Joint Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Joint Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Joint Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Joint Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Joint Disease Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Joint Disease Therapeutics Market Drivers
1.6.2 Joint Disease Therapeutics Market Restraints
1.6.3 Joint Disease Therapeutics Trends Analysis
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Joint Disease Therapeutics Product and Solutions
2.1.4 AbbVie Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Joint Disease Therapeutics Product and Solutions
2.2.4 Pfizer Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Joint Disease Therapeutics Product and Solutions
2.3.4 Bristol-Myers Squibb Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Joint Disease Therapeutics Product and Solutions
2.4.4 Roche Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Joint Disease Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Joint Disease Therapeutics Product and Solutions
2.6.4 AstraZeneca Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Astellas Pharma
2.7.1 Astellas Pharma Details
2.7.2 Astellas Pharma Major Business
2.7.3 Astellas Pharma Joint Disease Therapeutics Product and Solutions
2.7.4 Astellas Pharma Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Astellas Pharma Recent Developments and Future Plans
2.8 Johnson&Johnson
2.8.1 Johnson&Johnson Details
2.8.2 Johnson&Johnson Major Business
2.8.3 Johnson&Johnson Joint Disease Therapeutics Product and Solutions
2.8.4 Johnson&Johnson Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Johnson&Johnson Recent Developments and Future Plans
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Joint Disease Therapeutics Product and Solutions
2.9.4 Amgen Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Amgen Recent Developments and Future Plans
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Joint Disease Therapeutics Product and Solutions
2.10.4 Novartis Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Novartis Recent Developments and Future Plans
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Joint Disease Therapeutics Product and Solutions
2.11.4 Sanofi Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sanofi Recent Developments and Future Plans
2.12 Daiiachi Sankyo
2.12.1 Daiiachi Sankyo Details
2.12.2 Daiiachi Sankyo Major Business
2.12.3 Daiiachi Sankyo Joint Disease Therapeutics Product and Solutions
2.12.4 Daiiachi Sankyo Joint Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Daiiachi Sankyo Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Joint Disease Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Joint Disease Therapeutics Players Market Share
3.2.2 Top 10 Joint Disease Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Joint Disease Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Joint Disease Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Joint Disease Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Joint Disease Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Joint Disease Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Joint Disease Therapeutics Revenue by Type (2016-2026)
6.2 North America Joint Disease Therapeutics Revenue by Application (2016-2026)
6.3 North America Joint Disease Therapeutics Market Size by Country
6.3.1 North America Joint Disease Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Joint Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Joint Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Joint Disease Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Joint Disease Therapeutics Revenue by Type (2016-2026)
7.2 Europe Joint Disease Therapeutics Revenue by Application (2016-2026)
7.3 Europe Joint Disease Therapeutics Market Size by Country
7.3.1 Europe Joint Disease Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Joint Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Joint Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Joint Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Joint Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Joint Disease Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Joint Disease Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Joint Disease Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Joint Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Joint Disease Therapeutics Revenue by Region (2016-2026)
8.3.2 China Joint Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Joint Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Joint Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Joint Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Joint Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Joint Disease Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Joint Disease Therapeutics Revenue by Type (2016-2026)
9.2 South America Joint Disease Therapeutics Revenue by Application (2016-2026)
9.3 South America Joint Disease Therapeutics Market Size by Country
9.3.1 South America Joint Disease Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Joint Disease Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Joint Disease Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Joint Disease Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Joint Disease Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Joint Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Joint Disease Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Joint Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Joint Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Joint Disease Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Joint Disease Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Joint Disease Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Joint Disease Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Joint Disease Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Joint Disease Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie Joint Disease Therapeutics Product and Solutions
Table 9. AbbVie Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Joint Disease Therapeutics Product and Solutions
Table 13. Pfizer Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 15. Bristol-Myers Squibb Major Business
Table 16. Bristol-Myers Squibb Joint Disease Therapeutics Product and Solutions
Table 17. Bristol-Myers Squibb Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Joint Disease Therapeutics Product and Solutions
Table 21. Roche Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Joint Disease Therapeutics Product and Solutions
Table 25. GlaxoSmithKline Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 27. AstraZeneca Major Business
Table 28. AstraZeneca Joint Disease Therapeutics Product and Solutions
Table 29. AstraZeneca Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 31. Astellas Pharma Major Business
Table 32. Astellas Pharma Joint Disease Therapeutics Product and Solutions
Table 33. Astellas Pharma Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Johnson&Johnson Corporate Information, Head Office, and Major Competitors
Table 35. Johnson&Johnson Major Business
Table 36. Johnson&Johnson Joint Disease Therapeutics Product and Solutions
Table 37. Johnson&Johnson Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Amgen Corporate Information, Head Office, and Major Competitors
Table 39. Amgen Major Business
Table 40. Amgen Joint Disease Therapeutics Product and Solutions
Table 41. Amgen Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Novartis Corporate Information, Head Office, and Major Competitors
Table 43. Novartis Major Business
Table 44. Novartis Joint Disease Therapeutics Product and Solutions
Table 45. Novartis Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sanofi Corporate Information, Head Office, and Major Competitors
Table 47. Sanofi Major Business
Table 48. Sanofi Joint Disease Therapeutics Product and Solutions
Table 49. Sanofi Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Daiiachi Sankyo Corporate Information, Head Office, and Major Competitors
Table 51. Daiiachi Sankyo Major Business
Table 52. Daiiachi Sankyo Joint Disease Therapeutics Product and Solutions
Table 53. Daiiachi Sankyo Joint Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Joint Disease Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 55. Global Joint Disease Therapeutics Revenue Share by Players (2019-2021)
Table 56. Breakdown of Joint Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Joint Disease Therapeutics Players Head Office, Products and Services Provided
Table 58. Joint Disease Therapeutics Mergers & Acquisitions in the Past Five Years
Table 59. Joint Disease Therapeutics New Entrants and Expansion Plans
Table 60. Global Joint Disease Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 61. Global Joint Disease Therapeutics Revenue Share by Type (2016-2021)
Table 62. Global Joint Disease Therapeutics Revenue Forecast by Type (2021-2026)
Table 63. Global Joint Disease Therapeutics Revenue by Application (2016-2021)
Table 64. Global Joint Disease Therapeutics Revenue Forecast by Application (2021-2026)
Table 65. North America Joint Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Joint Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Joint Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Joint Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Joint Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Joint Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Joint Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Joint Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Joint Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Joint Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Joint Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Joint Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Joint Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Joint Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Joint Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Joint Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Joint Disease Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Joint Disease Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Joint Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Joint Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Joint Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Joint Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Joint Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Joint Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Joint Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Joint Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Joint Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Joint Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Joint Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Joint Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Joint Disease Therapeutics Picture
Figure 2. Global Joint Disease Therapeutics Revenue Market Share by Type in 2020
Figure 3. Drug Therapy
Figure 4. Rehabilitation
Figure 5. Surgical Operation
Figure 6. Joint Disease Therapeutics Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Others Picture
Figure 10. Global Joint Disease Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Joint Disease Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Joint Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 13. Global Joint Disease Therapeutics Revenue Market Share by Region in 2020
Figure 14. North America Joint Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Joint Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Joint Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Joint Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Joint Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Joint Disease Therapeutics Market Drivers
Figure 20. Joint Disease Therapeutics Market Restraints
Figure 21. Joint Disease Therapeutics Market Trends
Figure 22. AbbVie Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. GlaxoSmithKline Recent Developments and Future Plans
Figure 27. AstraZeneca Recent Developments and Future Plans
Figure 28. Astellas Pharma Recent Developments and Future Plans
Figure 29. Johnson&Johnson Recent Developments and Future Plans
Figure 30. Amgen Recent Developments and Future Plans
Figure 31. Novartis Recent Developments and Future Plans
Figure 32. Sanofi Recent Developments and Future Plans
Figure 33. Daiiachi Sankyo Recent Developments and Future Plans
Figure 34. Global Joint Disease Therapeutics Revenue Share by Players in 2020
Figure 35. Joint Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Joint Disease Therapeutics Revenue Market Share in 2020
Figure 37. Global Top 10 Players Joint Disease Therapeutics Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Joint Disease Therapeutics Revenue Share by Type in 2020
Figure 40. Global Joint Disease Therapeutics Market Share Forecast by Type (2021-2026)
Figure 41. Global Joint Disease Therapeutics Revenue Share by Application in 2020
Figure 42. Global Joint Disease Therapeutics Market Share Forecast by Application (2021-2026)
Figure 43. North America Joint Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 44. North America Joint Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 45. North America Joint Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 46. United States Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Joint Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 50. Europe Joint Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 51. Europe Joint Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 52. Germany Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Joint Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Joint Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Joint Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 60. China Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Joint Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 67. South America Joint Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 68. South America Joint Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Joint Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Joint Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Joint Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Joint Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source

---